This collaboration integrates BioSpark's proprietary AI and LLM platform with Fifty1 AI Labs' advanced predictive modeling to explore and organize extensive case-based medical literature. BioSpark's ...
VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), has entered a groundbreaking partnership with LUNR Aerospace ...
STANFORD, Calif., Aug. 22, 2025 (GLOBE NEWSWIRE) -- via IBN – ViRx@Stanford, a leading biosecurity and pandemic preparedness initiative, and Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: ...
BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 ...
Medindia on MSN
AI Tool Finds Hidden Drug Targets Across Cancers
DeepTarget, a next-gen AI tool, predicts cancer drug targets across tumor types and uncovers hidden mechanisms that enable ...
In a recently accepted manuscript titled “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data”, scientists from Insilico ...
Hosted on MSN
AI is helping doctors repurpose old drugs for new cures: 'The solution is in your neighborhood pharmacy'
When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...
Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...
"By combining our AI-driven drug repurposing capabilities with LUNR's plans for orbital infrastructure, we will not only be advancing space medicine but also unlock dual-use applications that could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback